Impact of inflammation on adverse cardiovascular events in patients with acute coronary syndromes.

Aims: Inflammation is a key factor in the long-term outcome of acute coronary syndromes (ACS). The aim of the present study was to evaluate inflammatory markers in patients with ACS as predictors for major adverse cardiovascular events (MACE) and hard events.

Methods: This study included 1548 patients with ACS.